Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk
International Journal of Cardiology · 2023
DOI: 10.1016/j.ijcard.2023.02.032 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Cardiology, 2023. Verfasst von Antonio Landi. Beteiligte Einrichtung: Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), CH-6900 Lugano, Switzerland; Department of Biomedical Sciences, University of Italia…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), CH-6900 Lugano, Switzerland; Department of Biomedical Sciences, University of Italian Switzerland, Lugano, Switzerland. Electronic address: antonio.landi@…
Zitieren
APA
Landi, A. (2023). Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2023.02.032
Vancouver
Landi A. Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk. International Journal of Cardiology. 2023. doi:10.1016/j.ijcard.2023.02.032
BibTeX
@article{Landi2023,
author = {Landi, Antonio},
title = {Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk},
journal = {International Journal of Cardiology},
year = {2023},
doi = {10.1016/j.ijcard.2023.02.032}
}
EUVIMED